Progress in the relationship between intestinal flora and intestinal
immune microenvironment in colorectal cancer patients

doi:10.3760/cma.j.issn.1007-1245.2022.24.002

International Medicine and Health Guidance News ›› 2022, Vol. 28 ›› Issue (24): 3419-.DOI: 10.3760/cma.j.issn.1007-1245.2022.24.002

• Scientific Research • Previous Articles Next Articles

Progress in the relationship between intestinal flora and intestinal immune microenvironment in colorectal cancer patients

Zhu Kun, Lu Qingjun, Ren Xiang, Jiang Hong

Departments of Colorectal Hernia Surgery, Binzhou Medical University Hospital, Binzhou 256000, China

Received:2022-08-24 Online:2022-12-15 Published:2022-12-16
Contact: Jiang Hong, Email: byfyjzcjh@126.com
Supported by:
"Research on Clinical Application of Minimally Invasive Surgery" of Science and Technology Development Center of National Health Commission (WA2021RW12); "Clinical + X" Project Fund of Binzhou Medical University (BY2021LCX21); Binzhou Medical University Scientific Research Plan and Scientific Research Start-up Fund (BY2019KYQD42, BY2019KJ11)

结直肠癌患者肠道菌群与肠道免疫微环境关系的研究进展

朱琨卢清军任翔蒋宏

滨州医学院附属医院结直肠疝外科，滨州　256000

通讯作者: 蒋宏，Email：byfyjzcjh@126.com
基金资助:
国家卫生健康委科技发展中心“微创手术临床应用规范研究”课题（WA2021RW12）；滨州医学院“临床+X”项目基金（BY2021LCX21）；滨州医学院科研计划与科研启动基金（BY2019KYQD42，BY2019KJ11）

Abstract

Abstract: Colorectal cancer (CRC) is one of the most commonly malignant tumors of digestive tract. Its occurrence and development are affected by many factors such as diet, genetics, and immunity. At present, more studies have turned to the role of intestinal flora in immune regulation of CRC. In this review, the composition of intestinal flora and the relationship between intestinal flora and intestinal immune microenvironment in CRC patients are studied, and we emphatically discuss the regulation of intestinal flora in intestinal immune microenvironment in CRC patients in order to provide a new way for the prevention and treatment of CRC.

Key words: Colorectal cancer, Intestinal flora, Intestinal immune microenvironment

摘要： 结直肠癌（colorectal cancer，CRC）是常见的消化道恶性肿瘤之一，其发生、发展与饮食、遗传及免疫等多种因素关系密切。目前，大量的基础及临床研究开始聚焦肠道菌群在CRC免疫调控中的作用。本文通过对CRC患者肠道菌群构成、肠道菌群与免疫微环境的关系等作一综述，重点分析CRC患者肠道菌群对肠道免疫微环境的调控，为CRC的预防及治疗提供新的研究思路。

关键词: 结直肠癌, 肠道菌群, 肠道免疫微环境

Zhu Kun, Lu Qingjun, Ren Xiang, Jiang Hong. Progress in the relationship between intestinal flora and intestinal immune microenvironment in colorectal cancer patients[J]. International Medicine and Health Guidance News, 2022, 28(24): 3419-.

朱琨卢清军任翔蒋宏. 结直肠癌患者肠道菌群与肠道免疫微环境关系的研究进展[J]. 国际医药卫生导报, 2022, 28(24): 3419-.

References

[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. DOI: 10.3322/caac.21660.
[2] Matson V, Chervin CS, Gajewski TF. Cancer and the microbiome-influence of the commensal microbiota on cancer, immune responses, and immunotherapy[J]. Gastroenterology, 2021, 160(2):600-613. DOI: 10.1053/j.gastro.2020.11.041.
[3] Yang YL, Zhou WW, Wu S, et al. Intestinal flora is a key factor in insulin resistance and contributes to the development of polycystic ovary syndrome[J]. Endocrinology, 2021, 162(10):bqab118. DOI: 10.1210/endocr/bqab118.
[4] Tilg H, Adolph TE, Gerner RR, et al. The intestinal microbiota in colorectal cancer[J]. Cancer Cell, 2018, 33(6):954-964. DOI: 10.1016/j.ccell.2018.03.004.
[5] Garrett WS. The gut microbiota and colon cancer[J]. Science, 2019, 364(6446):1133-1135. DOI: 10.1126/science.aaw2367.
[6] Depoortere I. Taste receptors of the gut: emerging roles in health and disease[J]. Gut, 2014, 63(1):179-190. DOI: 10.1136/gutjnl-2013-305112.
[7] Perez-Lopez A, Behnsen J, Nuccio SP, et al. Mucosal immunity to pathogenic intestinal bacteria[J]. Nat Rev Immunol, 2016, 16(3):135-148. DOI: 10.1038/nri.2015.17.
[8] Karin M, Clevers H. Reparative inflammation takes charge of tissue regeneration[J]. Nature, 2016, 529(7586):307-315. DOI: 10.1038/nature17039.
[9] Mu C, Yang Y, Zhu W. Crosstalk between the immune receptors and gut microbiota[J]. Curr Protein Pept Sci, 2015, 16(7):622-631. DOI: 10.2174/1389203716666150630134356.
[10] Velloso LA, Folli F, Saad MJ. TLR4 at the crossroads of nutrients, gut microbiota, and metabolic inflammation[J]. Endocr Rev, 2015, 36(3):245-271. DOI: 10.1210/er.2014-1100.
[11] Seo SU, Kamada N, Muñoz-Planillo R, et al. Distinct commensals induce interleukin-1β via NLRP3 inflammasome in inflammatory monocytes to promote intestinal inflammation in response to injury[J]. Immunity, 2015, 42(4):744-755. DOI: 10.1016/j.immuni.2015.03.004.
[12] Maynard CL, Elson CO, Hatton RD, et al. Reciprocal interactions of the intestinal microbiota and immune system[J]. Nature, 2012, 489(7415):231-241. DOI: 10.1038/nature11551.
[13] Montalvillo E, Garrote JA, Bernardo D, et al. Innate lymphoid cells and natural killer T cells in the gastrointestinal tract immune system[J]. Rev Esp Enferm Dig, 2014, 106(5):334-345.
[14] Turroni F, Ventura M, Buttó LF, et al. Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective[J]. Cell Mol Life Sci, 2014, 71(2):183-203. DOI: 10.1007/s00018-013-1318-0.
[15] Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense[J]. Immunity, 2008, 29(6):958-970. DOI: 10.1016/j.immuni.2008.11.001.
[16] Johansson ME, Phillipson M, Petersson J, et al. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria[J]. Proc Natl Acad Sci U S A, 2008, 105(39):15064-15069. DOI: 10.1073/pnas.0803124105.
[17] Wu S, Rhee KJ, Albesiano E, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses[J]. Nat Med, 2009, 15(9):1016-1022. DOI: 10.1038/nm.2015.
[18] Thiele Orberg E, Fan H, Tam AJ, et al. The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis[J]. Mucosal Immunol, 2017, 10(2):421-433. DOI: 10.1038/mi.2016.53.
[19] Chung L, Thiele Orberg E, Geis AL, et al. Bacteroides fragilis toxin coordinates a pro-carcinogenic inflammatory cascade via targeting of colonic epithelial cells[J]. Cell Host Microbe, 2018, 23(2):203-214.e5. DOI: 10.1016/j.chom.2018.01.007.
[20] Kim JM, Oh YK, Kim YJ, et al. Polarized secretion of CXC chemokines by human intestinal epithelial cells in response to Bacteroides fragilis enterotoxin: NF-kappa B plays a major role in the regulation of IL-8 expression[J]. Clin Exp Immunol, 2001, 123(3):421-427. DOI: 10.1046/j.1365-2249.2001.01462.x.
[21] Zhang Y, Weng Y, Gan H, et al. Streptococcus gallolyticus conspires myeloid cells to promote tumorigenesis of inflammatory bowel disease[J]. Biochem Biophys Res Commun, 2018, 506(4):907-911. DOI: 10.1016/j.bbrc.2018.10.136.
[22] Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment[J]. Cell Host Microbe, 2013, 14(2):207-215. DOI: 10.1016/j.chom.2013.07.007.
[23] Long X, Wong CC, Tong L, et al. Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity[J]. Nat Microbiol, 2019, 4(12):2319-2330. DOI: 10.1038/s41564-019-0541-3.
[24] Gur C, Ibrahim Y, Isaacson B, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack[J]. Immunity, 2015, 42(2):344-355. DOI: 10.1016/j.immuni.2015.01.010.
[25] Cremonesi E, Governa V, Garzon JFG, et al. Gut microbiota modulate T cell trafficking into human colorectal cancer[J]. Gut, 2018, 67(11):1984-1994. DOI: 10.1136/gutjnl-2016-313498.
[26] Thommen DS, Schumacher TN. T cell dysfunction in cancer[J]. Cancer Cell, 2018, 33(4):547-562. DOI: 10.1016/j.ccell.2018.03.012.
[27] Lavoie S, Chun E, Bae S, et al. Expression of free fatty acid receptor 2 by dendritic cells prevents their expression of interleukin 27 and is required for maintenance of mucosal barrier and immune response against colorectal tumors in mice[J]. Gastroenterology, 2020, 158(5):1359-1372.e9. DOI: 10.1053/j.gastro.2019.12.027.
[28] Grivennikov SI, Wang K, Mucida D, et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth[J]. Nature, 2012, 491(7423):254-258. DOI: 10.1038/nature11465.
[29] Wu P, Wu D, Ni C, et al. γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer[J]. Immunity, 2014, 40(5):785-800. DOI: 10.1016/j.immuni.2014.03.013.
[30] Ghoreschi K, Laurence A, Yang XP, et al. Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling[J]. Nature, 2010, 467(7318):967-971. DOI: 10.1038/nature09447.
[31] Couturier-Maillard A, Secher T, Rehman A, et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer[J]. J Clin Invest, 2013, 123(2):700-711. DOI: 10.1172/JCI62236.
[32] Dejea CM, Wick EC, Hechenbleikner EM, et al. Microbiota organization is a distinct feature of proximal colorectal cancers[J]. Proc Natl Acad Sci U S A, 2014, 111(51):18321-18326. DOI: 10.1073/pnas.1406199111.
[33] Hu B, Elinav E, Huber S, et al. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer[J]. Proc Natl Acad Sci U S A, 2013, 110(24):9862-9867. DOI: 10.1073/pnas.1307575110.
[34] Dmitrieva-Posocco O, Dzutsev A, Posocco DF, et al. Cell-type-specific responses to interleukin-1 control microbial invasion and tumor-elicited inflammation in colorectal cancer[J]. Immunity, 2019, 50(1):166-180.e7. DOI: 10.1016/j.immuni.2018.11.015.
[35] Yu T, Guo F, Yu Y, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy[J]. Cell, 2017, 170(3):548-563.e16. DOI: 10.1016/j.cell.2017.07.008.

Progress in the relationship between intestinal flora and intestinal immune microenvironment in colorectal cancer patients

结直肠癌患者肠道菌群与肠道免疫微环境关系的研究进展

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 8

Recommended Articles

Metrics

[1]	Liang Jiamin, Yang Zijian, Yang Jiwu, Liang Peiwen, Hu Shunqing. Changes of intestinal flora in elderly patients with postoperative delirium after hip arthroplasty [J]. International Medicine and Health Guidance News, 2022, 28(7): 957-961.
[2]	Liu Siping, Mao Haiyan. Multiphase contrast-enhanced MSCT in TN staging of colorectal cancer: comparative study with pathology [J]. International Medicine and Health Guidance News, 2022, 28(4): 464-467.
[3]	Zhao Wenzhen, Lin Yuning. LINC01836 is a new biomarker for the diagnosis and prognosis of colorectal cancer [J]. International Medicine and Health Guidance News, 2022, 28(3): 363-367.
[4]	Zhao Shengying, Yu Xiyang, Li Yan, Chen Weizhen, Dong Shulan. Neonatal hyperbilirubinemia and intestinal flora homeostasis and related influencing factors [J]. International Medicine and Health Guidance News, 2022, 28(3): 380-384.
[5]	Wang Chao, Yuan Zixu, Zhang Jiye, Cai Jian, Lei Binhua. Current status and influencing factors of dynamic intestinal obstruction after laparoscopic surgery in patients with colorectal cancer [J]. International Medicine and Health Guidance News, 2022, 28(16): 2221-2224.
[6]	Li Feng, Xuan Jinfeng, Gong Chao, Li jiongxian. Single hole laparoscopic radical resection for patients with colorectal cancer [J]. International Medicine and Health Guidance News, 2022, 28(13): 1829-1833.
[7]	He Tian, Cao Tiansheng. Screening of lncRNA related to prognosis of colon cancer based on TCGA database and establishment of prognostic risk model [J]. International Medicine and Health Guidance News, 2022, 28(13): 1864-1871.
[8]	Peng Shuling, Zhang Weihua, Zhong Yubo, Liu Lili, Huang Hongzhen. Effect of Jianpiyiqi prescription combined with acupoint application in prevention and treatment of chemotherapeutic gastrointestinal reactions after colorectal cancer surgery [J]. International Medicine and Health Guidance News, 2022, 28(11): 1516-1520.